Evropska unija - slovenščina - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated feline panleucopenia virus (pli iv), felv recombinant canarypox virus (vcp97), attenuated chlamydophila felis (905 strain) - immunologicals za skupin felidae, - mačke - active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs;against chlamydophila felis infection to reduce clinical signs;against feline panleucopenia to prevent mortality and clinical signs;against leukaemia to prevent persistent viraemia and clinical signs of the related disease. onsets of immunity are 1 week after primary vaccination course for rhinotracheitis, calicivirus, chlamydophila felis and panleucopenia components, and 2 weeks after primary vaccination course for feline leukaemia component. the duration of immunity is one year after the last re-vaccination for the chlamydiosis and feline leukaemia components, and one year after primary vaccination course and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.

Evropska unija - slovenščina - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated feline panleucopenia virus (pli iv), felv recombinant canarypox virus (vcp97) - immunologicals za skupin felidae, - mačke - active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs ;against feline panleucopenia to prevent mortality and clinical signs;against leukaemia to prevent persistent viraemia and clinical signs of the related disease. onsets of immunity are 1 week after primary vaccination course for rhinotracheitis, calicivirus and panleucopenia components, and 2 weeks after primary vaccination course for feline leukaemia component. the duration of immunity is one year after the last re-vaccination for the feline leukaemia component, and one year after primary vaccination course and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

alkaloid - int d.o.o. - buprenorfin; nalokson - podjezična tableta - buprenorfin 2 mg / 1 tableta  nalokson0,5 mg / 1 tableta; nalokson 0,5 mg / 1 tableta - buprenorfin, kombinacije

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

alkaloid - int d.o.o. - buprenorfin; nalokson - podjezična tableta - buprenorfin 2 mg / 1 tableta  nalokson0,5 mg / 1 tableta; nalokson 0,5 mg / 1 tableta - buprenorfin, kombinacije

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

alkaloid - int d.o.o. - buprenorfin; nalokson - podjezična tableta - buprenorfin 8 mg / 1 tableta  nalokson2 mg / 1 tableta; nalokson 2 mg / 1 tableta - buprenorfin, kombinacije

Evropska unija - slovenščina - EMA (European Medicines Agency)

astrazeneca ab - olaparib - ovarijske neoplazme - antineoplastična sredstva - ciste na cancerlynparza je označen kot monotherapy za:vzdrževanje zdravljenje odraslih bolnikov z napredovalim (figo fazah iii in iv) brca1/2-mutiral (germline in/ali somatski) high-grade epitelnih jajčnikov, fallopian tube ali primarni trebušno raka, ki so v odziv (popolna ali delna) po koncu prve vrstice platinum, ki temelji kemoterapijo. maintenance treatment of adult patients with platinum sensitive relapsed high grade epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in response (complete or partial) to platinum based chemotherapy. lynparza in combination with bevacizumab is indicated for the:maintenance treatment of adult patients with advanced (figo stages iii and iv) high-grade epithelial ovarian, fallopian tube or primary peritoneal cancer who are in response (complete or partial) following completion of first-line platinum-based chemotherapy in combination with bevacizumab and whose cancer is associated with homologous recombination deficiency (hrd) positive status defined by either a brca1/2 mutation and/or genomic instability (see section 5. breast cancerlynparza is indicated as:monotherapy or in combination with endocrine therapy for the adjuvant treatment of adult patients with germline brca1/2-mutations who have her2-negative, high risk early breast cancer previously treated with neoadjuvant or adjuvant chemotherapy (see sections 4. 2 in 5. monotherapy for the treatment of adult patients with germline brca1/2-mutations, who have her2 negative locally advanced or metastatic breast cancer. bolniki morajo imeti predhodno že bili zdravljeni z anthracycline in taxane v (neo)adjuvant ali metastatskim nastavitev, če bolniki niso bili primerni za temi postopki (glej točko 5. bolniki z hormon receptorjev (hr)-pozitivnega raka dojk, je treba tudi napredovala na ali po predhodnem endokrine terapije, ali neprimerna za endokrine terapija. adenocarcinoma of the pancreaslynparza is indicated as:monotherapy for the maintenance treatment of adult patients with germline brca1/2-mutations who have metastatic adenocarcinoma of the pancreas and have not progressed after a minimum of 16 weeks of platinum treatment within a first-line chemotherapy regimen. prostate cancerlynparza is indicated as:monotherapy for the treatment of adult patients with metastatic castration-resistant prostate cancer (mcrpc) and brca1/2-mutations (germline and/or somatic) who have progressed following prior therapy that included a new hormonal agent. in combination with abiraterone and prednisone or prednisolone for the treatment of adult patients with mcrpc in whom chemotherapy is not clinically indicated (see section 5.

Evropska unija - slovenščina - EMA (European Medicines Agency)

elanco gmbh - tulatromicin - antibakterij za sistemsko uporabo - cattle; pigs; sheep - cattle: treatment and metaphylaxis of bovine respiratory disease (brd) associated with mannheimia haemolytica, pasteurella multocida, histophilus somni and mycoplasma bovis susceptible to tulathromycin. prisotnost bolezni v čredi je treba določiti pred metafilaktičnim zdravljenjem. treatment of infectious bovine keratoconjunctivitis (ibk) associated with moraxella bovis susceptible to tulathromycin. pigs: treatment and metaphylaxis of swine respiratory disease (srd) associated with actinobacillus pleuropneumoniae, pasteurella multocida, mycoplasma hyopneumoniae, haemophilus parasuis and bordetella bronchiseptica susceptible to tulathromycin. prisotnost bolezni v čredi je treba določiti pred metafilaktičnim zdravljenjem. the product should only be used if pigs are expected to develop the disease within 2–3 days. ovce: zdravljenje zgodnjih fazah nalezljivih pododermatitis (stopala gnilobe), ki je povezana s sovražno dichelobacter nodosus, ki zahteva sistemsko zdravljenje.

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

fresenius kabi ab - glicin; glukoza, brezvodna; histidin; alanin; arginin; fenilalanin; izolevcin; levcin; lizin; metionin; prolin; serin; tirozin; treonin; triptofan; valin; olivno olje, rafinirano; sojino olje, rafinirano; trigliceridi, srednjeverižni, nasičeni; tavrin; ribje olje - emulzija za infundiranje - glicin 5,6 g / 1000 ml  glukoza, brezvodna127 g / 1000 ml  histidin1,5 g / 1000 ml  alanin7,1 g / 1000 ml  arginin6,1 g / 1000 ml  fenilalanin2,6 g / 1000 ml  izolevcin2,5 g / 1000 ml  levcin3,8 g / 1000 ml  lizin3,4 g / 1000 ml  metionin2,2 g / 1000 ml  prolin5,7 g / 1000 ml  serin3,3 g / 1000 ml  tirozin0,2 g / 1000 ml  treonin2,2 g / 1000 ml  triptofan1 g / 1000 ml  valin3,1 g / 1000 ml  olivno olje, rafinirano9,5 g / 1000 ml  sojino olje, rafinirano11,4 g / 1000 ml  trigliceridi, srednjeverižni, nasičeni11,4 g / 1000 ml  tavrin0,5 g / 1000 ml  ribje olje5,7 g / 1000 ml; glukoza, brezvodna 127 g / 1000 ml  histidin1,5 g / 1000 ml  alanin7,1 g / 1000 ml  arginin6,1 g / 1000 ml  fenilalanin2,6 g / 1000 ml  izolevcin2,5 g / 1000 ml  levcin3,8 g / 1000 ml  lizin3,4 g / 1000 ml  metionin2,2 g / 1000 ml  prolin5,7 g / 1000 ml  serin3,3 g / 1000 ml  tirozin0,2 g / 1000 ml  treonin2,2 g / 1000 ml  triptofan1 g / 1000 ml  valin3,1 g / 1000 ml  olivno olje, rafinirano9,5 g / 1000 ml  sojino olje, rafinirano11,4 g / 1000 ml  trigliceridi, srednjeverižni, nasičeni11,4 g / 1000 ml  tavrin0,5 g / 1000 ml  ribje olje5,7 g / 1000 ml; histidin 1,5 g / 1000 ml  alanin7,1 g / 1000 ml  arginin6,1 g / 1000 ml  fenilalanin2,6 g / 1000 ml  izolevcin2,5 g / 1000 ml  levcin3,8 g / 1000 ml  lizin3,4 g / 1000 ml  metionin2,2 g / 1000 ml  prolin5,7 g / 1000 ml  serin3,3 g / 1000 ml  tirozin0,2 g / 1000 ml  treonin2,2 g / 1000 ml  triptofan1 g / 1000 ml  valin3,1 g / 1000 ml  olivno olje, rafinirano9,5 g / 1000 ml  sojino olje, rafinirano11,4 g / 1000 ml  trigliceridi, srednjeverižni, nasičeni11,4 g / 1000 ml  tavrin0,5 g / 1000 ml  ribje olje5,7 g / 1000 ml; alanin 7,1 g / 1000 ml  arginin6,1 - kombinacije

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

fresenius kabi ab - glicin; glukoza, brezvodna; histidin; alanin; arginin; fenilalanin; izolevcin; levcin; lizin; metionin; prolin; serin; tirozin; treonin; triptofan; valin; olivno olje, rafinirano; sojino olje, rafinirano; trigliceridi, srednjeverižni, nasičeni; tavrin; ribje olje - emulzija za infundiranje - glicin 5,6 g / 1000 ml  glukoza, brezvodna127 g / 1000 ml  histidin1,5 g / 1000 ml  alanin7,1 g / 1000 ml  arginin6,1 g / 1000 ml  fenilalanin2,6 g / 1000 ml  izolevcin2,5 g / 1000 ml  levcin3,8 g / 1000 ml  lizin3,4 g / 1000 ml  metionin2,2 g / 1000 ml  prolin5,7 g / 1000 ml  serin3,3 g / 1000 ml  tirozin0,2 g / 1000 ml  treonin2,2 g / 1000 ml  triptofan1 g / 1000 ml  valin3,1 g / 1000 ml  olivno olje, rafinirano9,5 g / 1000 ml  sojino olje, rafinirano11,4 g / 1000 ml  trigliceridi, srednjeverižni, nasičeni11,4 g / 1000 ml  tavrin0,5 g / 1000 ml  ribje olje5,7 g / 1000 ml; glukoza, brezvodna 127 g / 1000 ml  histidin1,5 g / 1000 ml  alanin7,1 g / 1000 ml  arginin6,1 g / 1000 ml  fenilalanin2,6 g / 1000 ml  izolevcin2,5 g / 1000 ml  levcin3,8 g / 1000 ml  lizin3,4 g / 1000 ml  metionin2,2 g / 1000 ml  prolin5,7 g / 1000 ml  serin3,3 g / 1000 ml  tirozin0,2 g / 1000 ml  treonin2,2 g / 1000 ml  triptofan1 g / 1000 ml  valin3,1 g / 1000 ml  olivno olje, rafinirano9,5 g / 1000 ml  sojino olje, rafinirano11,4 g / 1000 ml  trigliceridi, srednjeverižni, nasičeni11,4 g / 1000 ml  tavrin0,5 g / 1000 ml  ribje olje5,7 g / 1000 ml; histidin 1,5 g / 1000 ml  alanin7,1 g / 1000 ml  arginin6,1 g / 1000 ml  fenilalanin2,6 g / 1000 ml  izolevcin2,5 g / 1000 ml  levcin3,8 g / 1000 ml  lizin3,4 g / 1000 ml  metionin2,2 g / 1000 ml  prolin5,7 g / 1000 ml  serin3,3 g / 1000 ml  tirozin0,2 g / 1000 ml  treonin2,2 g / 1000 ml  triptofan1 g / 1000 ml  valin3,1 g / 1000 ml  olivno olje, rafinirano9,5 g / 1000 ml  sojino olje, rafinirano11,4 g / 1000 ml  trigliceridi, srednjeverižni, nasičeni11,4 g / 1000 ml  tavrin0,5 g / 1000 ml  ribje olje5,7 g / 1000 ml; alanin 7,1 g / 1000 ml  arginin6,1 - kombinacije

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

fresenius kabi ab - glicin; glukoza, brezvodna; histidin; alanin; arginin; fenilalanin; izolevcin; levcin; lizin; metionin; prolin; serin; tirozin; treonin; triptofan; valin; olivno olje, rafinirano; sojino olje, rafinirano; trigliceridi, srednjeverižni, nasičeni; tavrin; ribje olje - emulzija za infundiranje - glicin 5,6 g / 1000 ml  glukoza, brezvodna127 g / 1000 ml  histidin1,5 g / 1000 ml  alanin7,1 g / 1000 ml  arginin6,1 g / 1000 ml  fenilalanin2,6 g / 1000 ml  izolevcin2,5 g / 1000 ml  levcin3,8 g / 1000 ml  lizin3,4 g / 1000 ml  metionin2,2 g / 1000 ml  prolin5,7 g / 1000 ml  serin3,3 g / 1000 ml  tirozin0,2 g / 1000 ml  treonin2,2 g / 1000 ml  triptofan1 g / 1000 ml  valin3,1 g / 1000 ml  olivno olje, rafinirano9,5 g / 1000 ml  sojino olje, rafinirano11,4 g / 1000 ml  trigliceridi, srednjeverižni, nasičeni11,4 g / 1000 ml  tavrin0,5 g / 1000 ml  ribje olje5,7 g / 1000 ml; glukoza, brezvodna 127 g / 1000 ml  histidin1,5 g / 1000 ml  alanin7,1 g / 1000 ml  arginin6,1 g / 1000 ml  fenilalanin2,6 g / 1000 ml  izolevcin2,5 g / 1000 ml  levcin3,8 g / 1000 ml  lizin3,4 g / 1000 ml  metionin2,2 g / 1000 ml  prolin5,7 g / 1000 ml  serin3,3 g / 1000 ml  tirozin0,2 g / 1000 ml  treonin2,2 g / 1000 ml  triptofan1 g / 1000 ml  valin3,1 g / 1000 ml  olivno olje, rafinirano9,5 g / 1000 ml  sojino olje, rafinirano11,4 g / 1000 ml  trigliceridi, srednjeverižni, nasičeni11,4 g / 1000 ml  tavrin0,5 g / 1000 ml  ribje olje5,7 g / 1000 ml; histidin 1,5 g / 1000 ml  alanin7,1 g / 1000 ml  arginin6,1 g / 1000 ml  fenilalanin2,6 g / 1000 ml  izolevcin2,5 g / 1000 ml  levcin3,8 g / 1000 ml  lizin3,4 g / 1000 ml  metionin2,2 g / 1000 ml  prolin5,7 g / 1000 ml  serin3,3 g / 1000 ml  tirozin0,2 g / 1000 ml  treonin2,2 g / 1000 ml  triptofan1 g / 1000 ml  valin3,1 g / 1000 ml  olivno olje, rafinirano9,5 g / 1000 ml  sojino olje, rafinirano11,4 g / 1000 ml  trigliceridi, srednjeverižni, nasičeni11,4 g / 1000 ml  tavrin0,5 g / 1000 ml  ribje olje5,7 g / 1000 ml; alanin 7,1 g / 1000 ml  arginin6,1 - kombinacije